Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference45 articles.
1. Global cancer statistics in the year 2000;Parking;Lancet Oncol,2001
2. Demographic aspects of breast cancer incidence and mortality in California, 1988–1999;Campleman,2004
3. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status;Glass;J Natl Cancer Inst,2007
4. The decrease in breast-cancer incidence in 2003 in the United States;Ravdin;N Engl J Med,2007
5. Molecular portraits of human breast tumours;Perou;Nature,2000
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer;npj Breast Cancer;2023-05-31
2. Valor pronóstico del índice de proliferación KI-67 en cánceres de mama luminales;Cirugía y Cirujanos;2023-02-22
3. CORRELATION BETWEEN PRIMARY TUMOR SIZES WITH PROGNOSTIC MARKERS IN BREAST CARCINOMA IN IRAQI WOMEN: IMMUNOHISTOCHEMICAL STUDY;Wiadomości Lekarskie;2022
4. Triple‐negative breast cancer and factors affecting disease‐free survival—Experience from a tertiary care center in India;The Breast Journal;2021-03-21
5. Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”;The Breast;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3